Advertisement
Research Article| Volume 19, P30-34, January 2018

Psychiatric morbidity develops after onset of pediatric multiple sclerosis: A Danish nationwide population-based study

Published:October 31, 2017DOI:https://doi.org/10.1016/j.msard.2017.10.018

      Highlights

      • Taken together, psychiatric morbidity seems to commence after onset of pediatric MS.
      • No association was found between psychiatric morbidity and the subsequent rate of MS (p=0.53).
      • Children with MS had a two times higher hazard for psychiatric co-morbidity compared with children without MS (p<0.001).

      Abstract

      Background

      Pediatric-onset multiple sclerosis (MS) affects life at a stage vital for social and educational achievements and psychiatric co-morbidity is common after MS onset. Few studies have examined psychiatric morbidity before MS onset.

      Methods

      In this nationwide study, detailed case ascertainment was performed in all children with pediatric MS, including chart review. For each MS patient, we selected five controls using density sampling from the entire Danish population, matching controls to children with MS by sex and birthdate. We analyzed data as a nested case-control study with psychiatric morbidity as exposure and MS as outcome, and a matched cohort study with MS as exposure and psychiatric co-morbidity as outcome. Hazard ratios (HR) including 95% confidence intervals (CI) were estimated using Cox regression.

      Results

      We identified 212 children with MS and 1060 controls. No association between psychiatric morbidity and the rate of MS was found before MS onset. After MS onset, children with MS had two times higher hazard for psychiatric co-morbidity compared with children without MS (HR=2.0; 95% CI=1.3–3.1; p<0.001).

      Conclusion

      Psychiatric morbidity seems to commence after MS onset, making screening for neuropsychiatric conditions pertinent in newly-diagnosed children with MS.

      Abbreviations:

      ATC (Anatomical Therapeutic Chemical), DMSR (Danish Multiple Sclerosis Registry), CI (Confidence intervals), HR (Hazard Ratio), ICD (International classification of diseases), NPR (National Patient Register), MS (Multiple Sclerosis), CNS (Central Nervous System)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aalen O.
        • Borgan Ø.
        • Gjessing H.
        Survival and Event History Analysis: A Process Point of View.
        Springer, 2008: 190-203
        • Amato M.P.
        • Goretti B.
        • Ghezzi A.
        • Lori S.
        • Zipoli V.
        • Portaccio E.
        • et al.
        Cognitive and psychosocial features of childhood and juvenile MS.
        Neurology. 2008; 70: 1891-1897
        • Andersen E.W.
        • Andersen P.K.
        Adjustment for misclassification in studies of familial aggregation of disease using routine register data.
        Stat. Med. 2002; 21: 3595-3607
        • Andersen J.S.
        • Olivarius N.D.F.
        • Krasnik A.
        The Danish national health service register.
        Scand. J. Public Health. 2011; 39: 34-37
        • Banwell B.L.
        • Anderson P.E.
        The cognitive burden of multiple sclerosis in children.
        Neurology. 2005; 64 (Mar 8): 891-894
        • Boesen M.S.
        • Sellebjerg F.
        • Blinkenberg M.
        Onset symptoms in paediatric multiple sclerosis.
        Dan. Med J. 2014; 61: A4800
        • Boesen M.S.
        • Magyari M.
        • Koch-Henrikse N.
        • Thygesen L.C.
        • Born A.P.
        • Uldall P.V.
        • et al.
        Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.
        Mult. Scler. 2017;
        • Borgan Ø.
        • Goldstein L.
        • Langholz B.
        Methods for the analysis of sampled cohort data in the cox proportional hazards model.
        Ann. Stat. 1995; 23: 1749-1778
        • Goretti B.
        • Ghezzi A.
        • Portaccio E.
        • Lori S.
        • Zipoli V.
        • Razzolini L.
        • et al.
        Psychosocial issue in children and adolescents with multiple sclerosis.
        Neurol. Sci. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 2010; 31: 467-470
        • Hoang H.
        • Laursen B.
        • Stenager E.N.
        • Stenager E.
        Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis.
        Mult. Scler. Houndmills Basingstoke Engl. 2016; 22: 347-353
        • Julian L.
        • Serafin D.
        • Charvet L.
        • Ackerson J.
        • Benedict R.
        • Braaten E.
        • et al.
        Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.
        J. Child Neurol. 2013; 28: 102-107
        • Koch-Henriksen N.
        • Rasmussen S.
        • Stenager E.
        • Madsen M.
        The Danish Multiple Sclerosis Registry. History, data collection and validity.
        Dan. Med Bull. 2001; 48: 91-94
        • Koch-Henriksen N.
        • Magyari M.
        • Laursen B.
        Registers of multiple sclerosis in Denmark.
        Acta Neurol. Scand. Suppl. 2015; 132: 4-10
        • Lynge E.
        • Sandegaard J.L.
        • Rebolj M.
        The Danish national patient register.
        Scand. J. Public Health. 2011; 39: 30-33
        • MacAllister W.S.
        • Belman A.L.
        • Milazzo M.
        • Weisbrot D.M.
        • Christodoulou C.
        • Scherl W.F.
        • et al.
        Cognitive functioning in children and adolescents with multiple sclerosis.
        Neurology. 2005; 64: 1422-1425
        • Pakpoor J.
        • Goldacre R.
        • Schmierer K.
        • Giovannoni G.
        • Waubant E.
        • Goldacre MJ.
        Psychiatric disorders in children with demyelinating diseases of the central nervous system.
        Mult Scler. 2017; (Jul 1; 1352458517719150)
        • Pedersen C.B.
        The Danish civil registration system.
        Scand. J. Public Health. 2011; 39: 22-25
        • Polman C.H.
        • Reingold S.C.
        • Edan G.
        • Filippi M.
        • Hartung H.-P.
        • Kappos L.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria.”.
        Ann. Neurol. 2005; 58: 840-846
        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • Clanet M.
        • Cohen J.A.
        • Filippi M.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
        Ann. Neurol. 2011; 69 (Feb 1): 292-302
        • Poser C.M.
        • Paty D.W.
        • Scheinberg L.
        • McDonald W.I.
        • Davis F.A.
        • Ebers G.C.
        • et al.
        New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
        Ann. Neurol. 1983; 13: 227-231
        • Renoux C.
        • Vukusic S.
        • Mikaeloff Y.
        • Edan G.
        • Clanet M.
        • Dubois B.
        • et al.
        Natural history of multiple sclerosis with childhood onset.
        N. Engl. J. Med. 2007; 356: 2603-2613
        • Rocca M.A.
        • Absinta M.
        • Amato M.P.
        • Moiola L.
        • Ghezzi A.
        • Veggiotti P.
        • et al.
        Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
        Neurology. 2014; 82: 1314-1321
      1. Statistikbanken [Internet]. [cited 2016 Oct 31]. Available from: 〈http://www.statistikbanken.dk/statbank5a/default.asp?W=1920〉.

        • Suissa S.
        Immortal time bias in observational studies of drug effects.
        Pharmacoepidemiol. Drug Saf. 2007; 16: 241-249
        • Suppiej A.
        • Cainelli E.
        Cognitive dysfunction in pediatric multiple sclerosis.
        Neuropsychiatr. Dis. Treat. 2014; 10: 1385-1392
      2. Thormann A., Magyari M., Koch-henriksen NJ, Laursen B., Sørensen PS. Bipolar disorder, schizophrenia and psychoses in multiple sclerosis: a population-based, nationwide study in Denmark: O2113. Eur J Neurol [Internet]. 2016 Jun 1 [cited 2017 May 15];23. Available from: 〈https://insights.ovid.com/european-neurology/ejneu/2016/06/002/bipolar-disorder-schizophrenia-psychoses-multiple/130/00054821〉.

        • Thygesen L.C.
        • Daasnes C.
        • Thaulow I.
        • Brønnum-Hansen H.
        Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving.
        Scand. J. Public Health. 2011; 39: 12-16
        • Till C.
        • Ghassemi R.
        • Aubert-Broche B.
        • Kerbrat A.
        • Collins D.L.
        • Narayanan S.
        • et al.
        MRI correlates of cognitive impairment in childhood-onset multiple sclerosis.
        Neuropsychology. 2011; 25: 319-332
        • Weisbrot D.M.
        • Ettinger A.B.
        • Gadow K.D.
        • Belman A.L.
        • MacAllister W.S.
        • Milazzo M.
        • et al.
        Psychiatric comorbidity in pediatric patients with demyelinating disorders.
        J. Child Neurol. 2010; 25: 192-202